Field safety notices: Cardionovum
Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.
1 authority publication by one authority, from 7 Jul 2020 to 7 Jul 2020.
Latest notice: 7 Jul 2020, IGJ, CARDIONOVUM GmbH, FSN-FO-40 no.11/2019, LEGFLOW OTW/RX Paclitaxel Releasing Peripheral Balloon Dilatation Catheter
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Cardionovum or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
1 distinct corrective action.
- CARDIONOVUM GmbH, FSN-FO-40 no.11/2019, LEGFLOW OTW/RX Paclitaxel Releasing Peripheral Balloon Dilatation Catheter
Bron: Inspectie Gezondheidszorg en Jeugd (IGJ), veiligheidswaarschuwingen (CC0) · collected 17 Nov 2026